[Use of pimozide (ORAP) in child psychiatry (author's transl)].
In a double blind cross-over study, pimozide was tested in 10 children with antisocial behavior. During two months, pimozide was administered orally between 1 and 2,6 mg per day. The use of a behavior scale permitted to conclude that pimozide improves social integration in the Socio-familial milieu.
D000987:Antisocial Personality Disorder / Q000188:drug therapy; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010554:Personality Disorders / Q000188:drug therapy*; D010868:Pimozide / Q000627:therapeutic use*
D010868:Pimozide
Utilisation du pimozide (ORAP) en pédo-psychiatrie.